Скачать с ютуб The role of fedratinib in 2024 and beyond в хорошем качестве
The role of fedratinib in 2024 and beyond
3 месяца назад
Speaker: Alexander Coltoff
Institution: Medical University of South Carolina
Event: MPN Workshop of the Carolinas 2024
Format: Interview
Subject: Myeloproliferative Neoplasms
Subject: Myelofibrosis
Subject: Chronic Myelomonocytic Leukemia
Field: Treatment
Medicines: Fedratinib
Medicines: Ruxolitinib
Medicines: Pacritinib
Medicines: Momelotinib
JAK inhibitors
thiamine supplementation
GI toxicity
BRD4
combination therapy
MDS/MPN Overlap
MPNs
Скачать бесплатно и смотреть ютуб-видео без блокировок The role of fedratinib in 2024 and beyond в качестве 4к (2к / 1080p)
У нас вы можете посмотреть бесплатно The role of fedratinib in 2024 and beyond или скачать в максимальном доступном качестве, которое было загружено на ютуб. Для скачивания выберите вариант из формы ниже:
Загрузить музыку / рингтон The role of fedratinib in 2024 and beyond в формате MP3:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса savevideohd.ru
The role of fedratinib in 2024 and beyond
Alexander Coltoff, MD, Medical University of South Carolina, Charleston, SC, discusses his talk on the role of fedratinib, the second JAK inhibitor approved in myelofibrosis (MF), in 2024 and beyond. Dr Coltoff suggests that the agent is sometimes forgotten about, despite its efficacy in ruxolitinib-resistant patients and in the frontline setting. Fedratinib inhibits BRD4 and is being studied in combination with other agents for the treatment of several hematological malignancies. This interview took place at the 1st Annual MPN Workshop of the Carolinas in Asheville, NC. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Comments
